DYADIC Int. INC. 1,459 € +3,84% Platz Berlin
Top-News
Neuester,
zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter
1 2 3 5 6 7 8 9 10 ...
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter 1 2 3 5 6 7 8 9 10 ...
DYADIC startet
Beiträge:
257
Zugriffe: 35.350 / Heute: 39
Zugriffe: 35.350 / Heute: 39
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI USA Banks UCITS ETF 1D
Perf. 12M: +70,66%
Xtrackers MSCI Pakistan Swap UCITS ETF 1C
Perf. 12M: +65,70%
Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C
Perf. 12M: +50,14%
Xtrackers MSCI USA Communication Services UCITS ETF 1D
Perf. 12M: +42,73%
Xtrackers MSCI Fintech Innovation UCITS ETF 1C
Perf. 12M: +41,39%
träumen vom Schicksal sie träumen von allem sie sind da vielleicht kennst Du sie sogar,Börse fetzt ;-)
Get Quote
Find Company Information
Sponsored By
OTC Markets
OTC Market Totals
9,916
Securities
$451,753,876
Dollar Volume
3,310,545,973
Share Volume
73,982
Trades
www.otcmarkets.com/stock/DYAI/quote)....ancial-Results-4218862
Find Company Information
Sponsored By
OTC Markets
OTC Market Totals
9,916
Securities
$451,753,876
Dollar Volume
3,310,545,973
Share Volume
73,982
Trades
www.otcmarkets.com/stock/DYAI/quote)....ancial-Results-4218862
buran
...(Perf. seit Threadbeginn: +116,67%)
...(Perf. seit Threadbeginn: +116,67%)
hier:
21.09.12 1,95 1,95§1,79 1,95 $ 47.344 58 T
20.09.12 1,95 1,95§1,90 1,95 $ 5.400 10.505
19.09.12 1,79 1,98§1,79 1,94 $ 16.700 30.917
18.09.12 1,98 1,98§1,76 1,94 $ 17.847 33.668
17.09.12 1,85 1,93§1,755 1,88 $ 6.373 11.601
14.09.12 1,94 1,99§1,90 1,95 $ 72.525 141 T
13.09.12 1,80 1,95§1,80 1,93 $ 71.892 136 T
12.09.12 1,94 1,94§1,84 1,85 $ 28.685 54 T
11.09.12 1,90 1,95§1,76 1,95 $ 34.478 65 T
10.09.12 1,72 1,95§1,72 1,90 $ 8.930 16.363
07.09.12 1,89 1,93§1,85 1,93 $ 52.770 100 T
06.09.12 1,90 1,90§1,75 1,89 $ 35.479 64 T
05.09.12 1,775 1,78§1,68 1,75 $ 41.870 73 T
04.09.12 1,40 1,74§1,40 1,74 $ 16.625 27.881
21.09.12 1,95 1,95§1,79 1,95 $ 47.344 58 T
20.09.12 1,95 1,95§1,90 1,95 $ 5.400 10.505
19.09.12 1,79 1,98§1,79 1,94 $ 16.700 30.917
18.09.12 1,98 1,98§1,76 1,94 $ 17.847 33.668
17.09.12 1,85 1,93§1,755 1,88 $ 6.373 11.601
14.09.12 1,94 1,99§1,90 1,95 $ 72.525 141 T
13.09.12 1,80 1,95§1,80 1,93 $ 71.892 136 T
12.09.12 1,94 1,94§1,84 1,85 $ 28.685 54 T
11.09.12 1,90 1,95§1,76 1,95 $ 34.478 65 T
10.09.12 1,72 1,95§1,72 1,90 $ 8.930 16.363
07.09.12 1,89 1,93§1,85 1,93 $ 52.770 100 T
06.09.12 1,90 1,90§1,75 1,89 $ 35.479 64 T
05.09.12 1,775 1,78§1,68 1,75 $ 41.870 73 T
04.09.12 1,40 1,74§1,40 1,74 $ 16.625 27.881
On Verifying Effective Enzymes For The Production Of Cellulosic Sugars
15:05 24.09.12
PR Newswire
JUPITER, Fla., Sept. 24, 2012
JUPITER, Fla., Sept. 24, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, announced today the results of its cooperation with SEKAB E-Technology on verifying effective enzymes for the degradation of cellulose into fermentable sugars as part of the recently concluded DISCO research project.
(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )
Dyadic's research and development center in the Netherlands along with SEKAB E-Technology participated in the DISCO project, a four year EU-funded research project conducted by a consortium of research institutes, universities and industrial partners from across Europe as well as Russia. The goal of the DISCO project was to identify and develop more productive and cost-effective enzymes for the production of bioethanol from lignocellulosic raw materials, a research area that is attracting considerable interest worldwide. As part of the DISCO project, Dyadic's biofuels enzyme, AlternaFuel® CMAX™ was successfully verified by SEKAB in the ethanol demonstration plant in Ornskoldsvik, Sweden.
"SEKAB has the expertise required to show if the results that we have seen at lab scale also work on a larger scale," said Jan Wery, Research Director at Dyadic Netherlands. "Such experiments are essential to show our customers the maturity and scalability of our newly developed lignocellulosic enzymes. The enzyme industry is growing rapidly, partly because of the increasing demand for lignocellulosic biofuels, and we are working continuously to offer new, more efficient products at lower prices."
Thore Lindgren, Executive Vice President of SEKAB E-Technology stated, "The goal for SEKAB E-Technology is to translate the knowledge and experience gained at the plant over the years into commercial ventures. The ethanol demonstration plant is a unique facility and the expertise gathered here allows us to test all the aspects of cellulose degradation in a way that few others can."
Cellulose is the main component in a variety of biomass, including waste from agriculture, forestry, wood-based industries and municipal solid waste. These materials which exist today in large quantities across the globe are renewable, do not compete with food production and can be converted into fermentable sugars for use in the production of second generation biofuels, bio-based chemicals and other bio-based products.
http://www.ariva.de/news/...e-Production-Of-Cellulosic-Sugars-4269328
15:05 24.09.12
PR Newswire
JUPITER, Fla., Sept. 24, 2012
JUPITER, Fla., Sept. 24, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, announced today the results of its cooperation with SEKAB E-Technology on verifying effective enzymes for the degradation of cellulose into fermentable sugars as part of the recently concluded DISCO research project.
(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )
Dyadic's research and development center in the Netherlands along with SEKAB E-Technology participated in the DISCO project, a four year EU-funded research project conducted by a consortium of research institutes, universities and industrial partners from across Europe as well as Russia. The goal of the DISCO project was to identify and develop more productive and cost-effective enzymes for the production of bioethanol from lignocellulosic raw materials, a research area that is attracting considerable interest worldwide. As part of the DISCO project, Dyadic's biofuels enzyme, AlternaFuel® CMAX™ was successfully verified by SEKAB in the ethanol demonstration plant in Ornskoldsvik, Sweden.
"SEKAB has the expertise required to show if the results that we have seen at lab scale also work on a larger scale," said Jan Wery, Research Director at Dyadic Netherlands. "Such experiments are essential to show our customers the maturity and scalability of our newly developed lignocellulosic enzymes. The enzyme industry is growing rapidly, partly because of the increasing demand for lignocellulosic biofuels, and we are working continuously to offer new, more efficient products at lower prices."
Thore Lindgren, Executive Vice President of SEKAB E-Technology stated, "The goal for SEKAB E-Technology is to translate the knowledge and experience gained at the plant over the years into commercial ventures. The ethanol demonstration plant is a unique facility and the expertise gathered here allows us to test all the aspects of cellulose degradation in a way that few others can."
Cellulose is the main component in a variety of biomass, including waste from agriculture, forestry, wood-based industries and municipal solid waste. These materials which exist today in large quantities across the globe are renewable, do not compete with food production and can be converted into fermentable sugars for use in the production of second generation biofuels, bio-based chemicals and other bio-based products.
http://www.ariva.de/news/...e-Production-Of-Cellulosic-Sugars-4269328
die regelrechten Kampfatacken:
20.09.12 1,95 1,95§1,90 1,95 $ 5.400 10.505
19.09.12 1,79 1,98§1,79 1,94 $ 16.700 30.917
18.09.12 1,98 1,98§1,76 1,94 $ 17.847 33.668
17.09.12 1,85 1,93§1,755 1,88 $ 6.373 11.601
da wurde richtig gedeckelt,SAHNE
20.09.12 1,95 1,95§1,90 1,95 $ 5.400 10.505
19.09.12 1,79 1,98§1,79 1,94 $ 16.700 30.917
18.09.12 1,98 1,98§1,76 1,94 $ 17.847 33.668
17.09.12 1,85 1,93§1,755 1,88 $ 6.373 11.601
da wurde richtig gedeckelt,SAHNE
21:05 24.09.12
PR Newswire
JUPITER, Fla., Sept. 24, 2012
JUPITER, Fla., Sept. 24, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has been issued U.S. Patent No. 8,268,585 entitled, "Transformation System in the Field of Filamentous Fungal Hosts" by the United States Patent and Trademark Office ("USPTO").
(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO)
Dyadic's President and CEO, Mark Emalfarb, stated, "We are very excited to have been granted this new U.S. patent containing such broad and encompassing claims that provide additional protection for the C1 fungal expression system for Dyadic, its customers and licensees."
The inventions embodied by this patent describe methods of developing, programming and growing improved strains of the fungal microorganisms which make up Dyadic's C1 platform technology. The patent claims cover the construction and use of C1 strains for the economical over-production of enzymes and other proteins at industrial scale for a broad number of applications such as food, animal feed, fuels and pharmaceuticals as well as primary and secondary metabolites such as organic acids and antibiotics.
Several of the issued patent claims relate to commercially advantageous properties of improved C1 strains which grow under low viscosity conditions and produce the targeted enzyme or other protein in a cleaner background which enhances the quality, quantity and cost-effectiveness of the final products. The patent also covers several molecular tools such as promoters and vectors which are integral to the process of gene expression resulting in higher productivity levels of enzymes and other proteins.
This patent is the eleventh U.S. patent issued to Dyadic adding to its portfolio of 58 international patents, 38 pending international and 13 pending U.S. patent applications which cover various features of Dyadic's proprietary technologies.
The newly issued patent is accessible on the USPTO's website at www.uspto.gov or on Dyadic's website at www.dyadic.com.http://www.ariva.de/news/...adic-International-4269809
PR Newswire
JUPITER, Fla., Sept. 24, 2012
JUPITER, Fla., Sept. 24, 2012 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has been issued U.S. Patent No. 8,268,585 entitled, "Transformation System in the Field of Filamentous Fungal Hosts" by the United States Patent and Trademark Office ("USPTO").
(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO)
Dyadic's President and CEO, Mark Emalfarb, stated, "We are very excited to have been granted this new U.S. patent containing such broad and encompassing claims that provide additional protection for the C1 fungal expression system for Dyadic, its customers and licensees."
The inventions embodied by this patent describe methods of developing, programming and growing improved strains of the fungal microorganisms which make up Dyadic's C1 platform technology. The patent claims cover the construction and use of C1 strains for the economical over-production of enzymes and other proteins at industrial scale for a broad number of applications such as food, animal feed, fuels and pharmaceuticals as well as primary and secondary metabolites such as organic acids and antibiotics.
Several of the issued patent claims relate to commercially advantageous properties of improved C1 strains which grow under low viscosity conditions and produce the targeted enzyme or other protein in a cleaner background which enhances the quality, quantity and cost-effectiveness of the final products. The patent also covers several molecular tools such as promoters and vectors which are integral to the process of gene expression resulting in higher productivity levels of enzymes and other proteins.
This patent is the eleventh U.S. patent issued to Dyadic adding to its portfolio of 58 international patents, 38 pending international and 13 pending U.S. patent applications which cover various features of Dyadic's proprietary technologies.
The newly issued patent is accessible on the USPTO's website at www.uspto.gov or on Dyadic's website at www.dyadic.com.http://www.ariva.de/news/...adic-International-4269809
was am 26ten reingedonnert wurde,konnte man sich behutsam mit kleinem Kursrücksetzer verbunden mit Gewinn rausnehmen,so funktionierts - jedenfalls dosiert
...sieht so aus:
Datum Erster Hoch Tief§Schluss Stücke Volumen
27.09.12 1,75 1,81§1,59 1,75 $ 15.550 27.892
26.09.12 1,78 1,84§1,60 1,80 $ 43.780 45.522
...sieht so aus:
Datum Erster Hoch Tief§Schluss Stücke Volumen
27.09.12 1,75 1,81§1,59 1,75 $ 15.550 27.892
26.09.12 1,78 1,84§1,60 1,80 $ 43.780 45.522
Handelsplatz Letzter Veränderung Vortag letzte Stk. Tag-Stk. Kursspanne Zeit
Frankfurt 1,371 € +3,23% 1,328 € 0 0 1,371 - 1,371 08:01:44
Berlin 1,371 € +3,23% 1,328 € 0 0 1,371 - 1,371 08:04:59
Nasdaq OTC Other 1,80 $ +3,44% 1,74 $ 100 46.700 1,63 - 1,80 01.10.12
__________________________________________________
alles eng beieinander HAMMER das wird ein Rennen ;-)
Frankfurt 1,371 € +3,23% 1,328 € 0 0 1,371 - 1,371 08:01:44
Berlin 1,371 € +3,23% 1,328 € 0 0 1,371 - 1,371 08:04:59
Nasdaq OTC Other 1,80 $ +3,44% 1,74 $ 100 46.700 1,63 - 1,80 01.10.12
__________________________________________________
alles eng beieinander HAMMER das wird ein Rennen ;-)
nehmt zu viel Teile raus,sonst kacken wir zu sehr ab,danke
buran
buran
für 1,337 € zu erhaschen,Nasdaq wird noch nicht angezeigt,reiche ich aber bei Anzeige natürlich nach,buran und tau
Datum Erster Hoch Tief Schluss Stücke Volumen
04.10.12 1,62 1,80§1,56 1,80 $ 70.791 114 T <<< WOW !!
__________________________________________________
mein lieber komm mit Du,das war echt heftig
04.10.12 1,62 1,80§1,56 1,80 $ 70.791 114 T <<< WOW !!
__________________________________________________
mein lieber komm mit Du,das war echt heftig
+4,29% gut raufgekommen drüben beim letzten update,bravo
Uhrenabgleich 12:42 MEZ (Mittel Europische Zeit) Abfahrt 15:30
ich glaube hier können wir ne Schippe mehr draufpacken,Kurs wird derzeit vom DAX runtergezogen,wenn dann bänggggg bängggggg ... hier::DAX 7.271 -0,15%
>>> 1,74 $ +6,09% +0,10 $ In Euro: 1,3442 € | Nasdaq OTC Other, 18:26
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem Dyadic International Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 256 | DYADIC startet | buran | Biotechboy | 24.04.21 12:15 | |
| 1 | DYADIC INTL INC. DL-,001 | SuperTenere | berlin25m | 13.03.09 10:12 |
